Treace Medical Concepts
TMCI
83 hedge funds and large institutions have $332M invested in Treace Medical Concepts in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 20 reducing their positions, and 5 closing their positions.
200% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 5
75% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 20
11% more funds holding
Funds holding: 75 → 83 (+8)
4.56% more ownership
Funds ownership: 37.23% → 41.78% (+4.6%)
14% less capital invested
Capital invested by funds: $385M → $332M (-$53.8M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
+$13.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.5M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$7.84M |
| 4 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
+$4.9M |
| 5 |
BlackRock
New York
|
+$4.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.94M |
| 2 |
Millennium Management
New York
|
-$5.32M |
| 3 |
RC
Roubaix Capital
Denver,
Colorado
|
-$2.03M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$702K |
| 5 |
Man Group
London,
United Kingdom
|
-$675K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Ensign Peak Advisors
Salt Lake City,
Utah
| $13K | – | – | – |
|
|
77
Fidelity Investments
Boston,
Massachusetts
| $12K | -$6.94M | -411,811 | -100% |
|
78
UBS Group
Zurich,
Switzerland
| $11K | +$11.9K | +705 | +705% |
|
|
CSS
79
Cubist Systematic Strategies
Stamford,
Connecticut
| $9K | -$35K | -2,077 | -78% |
|
|
SJIM
80
St. Johns Investment Management
Jacksonville,
Florida
| $9K | – | – | – |
|
81
Royal Bank of Canada
Toronto,
Ontario, Canada
| $6K | -$29.6K | -1,760 | -82% |
|
82
Osaic Holdings
Scottsdale,
Arizona
| $3K | +$3.37K | +200 | New |
|
|
TI
83
Trexquant Investment
Stamford,
Connecticut
| – | -$469K | -24,780 | Closed |
|
84
Balyasny Asset Management
Chicago,
Illinois
| – | -$380K | -20,109 | Closed |
|
|
T
85
TCWP
Beachwood,
Ohio
| – | -$4K | -215 | Closed |
|
86
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$1K | -64 | Closed |
|
|
C
87
Covestor
London,
United Kingdom
| – | +$185 | +11 | New |
|
88
Bank of Montreal
Toronto,
Ontario, Canada
| – | +$438 | +26 | New |
|
TMCI Hedge Fund Activity: Q2 2022 in Review
83 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q2 2022, worth a combined $332M — down 14% from $385M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new TMCI positions and 5 closed out — a net gain of 10 holders — while 35 added to existing stakes and 20 trimmed.
The largest buyer was William Blair Investment Management, opening a new position worth an estimated $13.8M. The largest seller was Fidelity Investments, cutting an estimated $6.94M.
- 83 institutional investors held Treace Medical Concepts (TMCI) as of Q2 2022, up from 75 in Q1 2022.
- Funds reported $332M of Treace Medical Concepts stock for Q2 2022, down 14% quarter-over-quarter.
- 15 funds opened new Treace Medical Concepts positions in Q2 2022 and 5 closed out, a net change of +10 holders.
- The largest Treace Medical Concepts buyer in Q2 2022 was William Blair Investment Management, an estimated $13.8M added.
- The largest Treace Medical Concepts seller in Q2 2022 was Fidelity Investments, an estimated $6.94M sold.
Based on aggregated 13F filings for Q2 2022.